FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/06/019711 [Registered on: 17/06/2019] Trial Registered Prospectively
Last Modified On: 16/06/2019
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A Comparison of Midazolam and Dexmedetomidine as Medication to be given in Nose before Anesthesia in Lower Body Surgeries of Children 
Scientific Title of Study   A Comparative Analysis of Intranasal Midazolam and Intranasal Dexmedetomidine as Premedication in Pediatric Infraumbilical Surgeries: A Prospective Randomized Double-blind Study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Aikta Gupta 
Designation  Specialist Grade-I 
Affiliation  Chacha Nehru Bal Chikitsalaya, New Delhi 
Address  Department of Anesthesia Chacha Nehru Bal Chikitsalaya Geeta Colony Delhi

East
DELHI
110031
India 
Phone  9643308230  
Fax    
Email  aiktab@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Payaswinee Sharma 
Designation  Fellow in Pediatric Anesthesia 
Affiliation  Chacha Nehru Bal Chikitsalaya, New Delhi 
Address  Department of Anesthesia Chacha Nehru Bal Chikitsalaya Geeta Colony Delhi

East
DELHI
110031
India 
Phone  9200022287  
Fax    
Email  payaswinee87@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Payaswinee Sharma 
Designation  Fellow in Pediatric Anesthesia 
Affiliation  Chacha Nehru Bal Chikitsalaya, New Delhi 
Address  Department of Anesthesia Chacha Nehru Bal Chikitsalaya Geeta Colony Delhi

East
DELHI
110031
India 
Phone  9200022287  
Fax    
Email  payaswinee87@gmail.com  
 
Source of Monetary or Material Support  
Chacha Nehru Bal Chikitsalaya, Delhi 
 
Primary Sponsor  
Name  Dr Aikta Gupta 
Address  Specialist Grade I, Department of Anesthesia, Chacha Nehru Bal Chikitsalaya, Geeta Colony, New Delhi, Pin 110031 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aikta Gupta  Chahcha Nehru Bal Chikitsalaya   Department of Anesthesia, 2nd Floor, Chacha Nehru Bal Chikitsalaya, Geeta Colony Delhi - 110031
East
DELHI 
9643308230

aiktab@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Chacha Nehru Bal Chikitsalaya, New Delhi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Q00-Q99||Congenital malformations, deformations and chromosomal abnormalities,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dexmedetomidine  Intranasal instillation 30 minutes prior to induction of anesthesia in dose of 0.5 mcg per kg body weight over duration of 30 seconds once only  
Comparator Agent  Midazolam  Intransal instillation 30 minutes prior to iduction of anesthesia in dose of 0.2 mg per kg body weight over duration of 30 seconds once only 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  10.00 Year(s)
Gender  Both 
Details  1. Children undergoing infraumbilical surgeries
2. ASA grade I and II 
 
ExclusionCriteria 
Details  1. Patients having known allergy to the drugs used in study
2. Patients having upper respiratory infection
3. Patients having neurological disorders
4. Patients under treatment with anticonvulsants/sedatives
5. Patients spitting out the medication
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Preoperative Sedation Score  Prior to administration of study drugs and thereafter every 10 minutes till patients in shifted into operating room  
 
Secondary Outcome  
Outcome  TimePoints 
Parental separation score  At the time of shifting into operating room 
Mask acceptance score
 
At the time of induction of anesthesia 
Preoperative and intraoperative vital parameters
 
Prior to administration of study drugs and thereafter every 10 minutes until completion of surgery and shifting of patient into post anesthesia care unit 
Postoperative emergence (Cravero score)  After completion of surgery and shifting into post anesthesia care unit 
Immediate postoperative sedation score  After completion of surgery and shifting into post anesthesia care unit 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/06/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

This study is a hospital-based, prospective, comparative, randomized, double-blind study to be conducted at Department of Anesthesia, Chacha Nehru Bal Chikitsalaya, New Delhi. The inclusion criteria are children aged 2-10 years undergoing elective infraumbilical surgeries of ASA grade I and II. 70 patients will be allocated in two groups, Group A (receiving intranasal midazolam 0.2 mg/kg) and Group B (intranasal dexmedetomidine 0.5 mcg/kg). The primary outcome measure is preoperative sedation score at the time of shifting into OT and the secondary outcome measure are parental separation score, mask acceptance score, preoperative and intraoperative vital parameters, postoperative emergence (Cravero score) and immediate postoperative sedation score. 

 
Close